The status of antimicrobial resistance of Helicobacter pylori in eastern Europe

Clinical Microbiology and Infection

Volumn 8, Issue 7, 2002, Pages 388-396

  Boyanova, L ^a,p   Mentis, A ^b   Gubina, M ^c   Rozynek, E ^d   Gosciniak, G ^e   Kalenic, S ^f   Goral V ^g   Kupcinskas, L ^h   Kantarceken B ⁱ   Aydin, A ^j   Archimandritis, A ^k   Dzierzanowska, D ^d   Vcev, A ^l   Ivanova, K ^m   Marina, M ^m   Mitov, I ^a   Petrov, P ^m   Ozden A ⁿ   Popova, M ^o  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

^c Institute of Microbiology and Immunology   (Slovenia)

^d CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^e WROCLAW MEDICAL UNIVERSITY   (Poland)

^f KBC Zagreb   (Croatia)

^g Dicle Universty   (Turkey)

^h KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

ⁱ INONU UNIVERSITY   (Turkey)

^j EGE UNIVERSITY   (Turkey)

^k UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^l UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^m NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

ⁿ ANKARA UNIVERSITY   (Turkey)

^o Drug Agency   (Bulgaria)

^p NONE   (Bulgaria)

more..

Author keywords

Children; Clarithromycin; Eastern Europe; H. pylori; Metronidazole; Resistance

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE;

ADULT; AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BULGARIA; CHILD; CONTROLLED STUDY; CROATIA; CZECH REPUBLIC; EASTERN EUROPE; ESTONIA; GEOGRAPHIC DISTRIBUTION; GREECE; HELICOBACTER PYLORI; HUMAN; LITHUANIA; MAJOR CLINICAL STUDY; METHODOLOGY; POLAND; PRIORITY JOURNAL; RUSSIAN FEDERATION; SLOVENIA; TURKEY (REPUBLIC);

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 0036630233     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00435.x     Document Type: Article

References (39)

1. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: The MACH 2 study
2. Helicobacter pylori resistance to antibiotics
3. Treatment of Helicobacter pylori infection
4. Resistance of Helicobacter pylori to antibiotics
5. Antibiotic susceptibility of H. pylori in Europe in 1998: Results of the third multicenter study
6. Activities of β-lactams and macrolides against Helicobacter pylori
7. Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins
8. Six year follow-up of resistance to antibiotics of Helicobacter pylori in Bordeaux, France
9. Evolution of H. pylori primary resistance to antimicrobial agents in Moscow (Russia) in 1996-1998
10. Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection
11. Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia
12. The relationship between gastroduodenal diseases and Helicobacter pylori infection
13. Helicobacter pylori susceptibility to antibiotics is not related to efficacy of anti-HP therapies
14. Sensitivity of Helicobacter pylori to eight antibiotics
15. Primary resistance of Helicobacter pylori to macrolides and metronidazole
16. The primary resistance of Helicobacter pylori strains Isolated from gastric biopsy specimens obtained from children during 1997-1999
17. Susceptibility of Helicobacter pylori strains isolated from children with gastritis to selected antibiotics
18. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria
19. Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years
20. Determination of primary resistance of Helicobacter pylori isolates to clarithromycin and amoxicillin by disc diffusion method and the comparison with resistance in recurrent cases
21. In vitro activity of metronidazole against H. pylori as determined by agar dilution method and in vitro activity of amoxicillin and clarithromycin against H. pylori as determined by disk diffusion method
22. Helicobacter pylori and antibiotic resistance
23. Helicobacter pylori "nin klaritromisine duyarliligi azaliyor mu?
24. Helicobacter pylori infeksiyonunda antibiyotic direnci
25. Impact of resistance to metronidazole on cure rate of Helicobacter pylori infections
26. Isolation of Helicobacter pylori and evaluation of its susceptibility to different antimicrobial agents
27. Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin and clarithromycin
28. Lansoprazole (LAN) vs. ranitidine bismuth citrate (RBC) based short-term triple therapies for Helicobacter pylori (H. pylori) eradication: A randomized study with 6-month follow-up
29. Comparative evaluation of the E test, agar dilution and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents
30. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin-influence on treatment outcome
31. Performance standards for antimicrobial susceptibility testing, tenth informational supplement
32. Antibiotic resistance in Helicobacter pylori infection
33. Assessment of metronidazole susceptibility in Helicobacter pylori: Statistical validation and error rate analysis of breakpoints determined by the disk diffusion test
34. Validation of a disk diffusion method for macrolide susceptibility testing of Helicobacter pylori
35. Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution and disk diffusion for ampicillin, clarithromycin and metronidazole
36. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Netherlands
37. A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children
38. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children